Emory University: Clinical Trials

1,854 trials sponsored by Emory University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1125 completed, 258 recruiting, 197 terminated, 95 withdrawn. 811 Not applicable, 305 Phase 2, 180 Phase 4, 174 Phase 1, 87 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable811Completed 524, Recruiting 126, Terminated 55, Withdrawn 32, Not yet recruiting 30, Active not recruiting 20, Unknown 13, Enrolling by invitation 6, Suspended 5
Phase 2305Completed 141, Terminated 56, Recruiting 50, Active not recruiting 24, Withdrawn 19, Not yet recruiting 10, Unknown 3, Enrolling by invitation 1, Suspended 1
Phase 4180Completed 117, Terminated 24, Recruiting 20, Withdrawn 11, Active not recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1, Unknown 1
Phase 1174Completed 100, Recruiting 26, Terminated 23, Withdrawn 9, Active not recruiting 8, Not yet recruiting 5, Unknown 3
Phase 387Completed 50, Terminated 11, Recruiting 9, Withdrawn 9, Active not recruiting 3, Unknown 3, Not yet recruiting 2
Early Phase 128Completed 13, Recruiting 7, Terminated 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1

Follow Emory University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta
Health MPowerment App - HIV Infections
Not applicableNot yet recruitingEmory University102027-04-012026-09-22
Advancing Ethical Goals In Society Trial
ACP Counselor Video Program - Advance Care Planning, Dementia
Not applicableNot yet recruitingTufts Medical Center121742027-03-012026-09-17
Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
No Marginal Cost Interventions, Low-Marginal Cost Interventions, Standard of Care - Human Immunodeficiency Virus
Not applicableNot yet recruitingEmory University2231652027-03-012026-09-16
Comparison of Sepsis Prediction Algorithms
Epic Sepsis Model Version - 1, Epic Sepsis Model Version - 2, Emory Sepsis Model - Sepsis
Not yet recruitingEmory University12002027-03-012026-10-26
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior
CLT- Concrete text messages, CLT- Abstract text messages, Control messages - HIV, Risk Behavior
Not applicableNot yet recruitingEmory University2402027-02-012026-08-19
Multimodal Differences in Effort-based Decision-Making in Depression
Effort-based Decision-Making Task - Depression, Anhedonia
Not applicableNot yet recruitingGeorgia Institute of Technology902027-01-012026-08-27
Quantifying Multi-step Avoidance in Anxiety
Behavioral Tasks with imaging - Anxiety, Anxiety Disorders
Not applicableNot yet recruitingEmory University1632027-01-012026-10-05
Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)
Bone marrow-derived mesenchymal stromal cells (MSCs) - Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III
Phase 1 / Phase 2Not yet recruitingEmory University122027-01-012026-05-08
Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial
Best Practice, Health Promotion and Education, HPV Self-Collection - HIV Infection, Human Papillomavirus-Related Cervical Carcinoma
Not applicableNot yet recruitingEmory University22802026-12-312026-09-17
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Psilocybin (Usona Institute) - Aging, Longevity
Phase 1Not yet recruitingCharles Raison502026-12-012026-10-13
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment, Dose Level 3 ACU-D1 ointment - Human Papilloma Virus, Human Immunodeficiency Virus
Phase 1Not yet recruitingEmory University92026-12-012026-08-18
A Human Influenza Transmission Study Using Naturally Infected Community Donors
Influenza Donor Visit, Influenza Recipient Inpatient Exposures Sessions - Influenza
Not applicableNot yet recruitingEmory University1502026-12-012026-09-11
Electrophysiologic Mechanisms of Ketamine Antidepressant Response
Ketamine - Epilepsy, Depressive Symptoms
Phase 2Not yet recruitingEmory University372026-12-012026-08-17
Neurocomputational Dynamics of Cooperation
Social Learning Task Battery, Clinical Cohort, Social Learning Task Battery, Online Cohort - Social Cognition, Personality Disorder
Not applicableNot yet recruitingUniversity of Pittsburgh16122026-12-012026-10-06
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
Continuous Glucose Monitoring (CGM) - End Stage Kidney Disease (ESKD), Hyperglycaemia
Not yet recruitingEmory University1802026-12-012026-10-19
CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer
Magnetic Resonance Imaging, Questionnaire Administration - Prostate Carcinoma, Stage I Prostate Cancer AJCC v8
Not applicableNot yet recruitingEmory University1002026-11-022026-10-09
Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer
Biopsy Procedure, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2Not yet recruitingEmory University882026-11-022026-10-06
PFAS Clinical Trial
Cholestyramine, Centrum - Environmental Exposure
Phase 2Not yet recruitingEmory University3002026-11-012026-09-23
CGM Use in Heart Failure
Libre 2 rt-CGM, POC BG + Blinded CGM - Heart Failure, Diabetes Mellitus
Not applicableNot yet recruitingEmory University1402026-11-012026-07-22

Showing 20 of 1854. Sign in to see all of them.

Conditions studied

Diabetes Mellitus (67)  ·  Depression (63)  ·  Acquired Immunodeficiency Syndrome (53)  ·  Diabetes Mellitus, Type 2 (44)  ·  Breast Neoplasms (43)  ·  Neoplasms (41)  ·  Stress Disorders, Post-Traumatic (39)  ·  Anemia, Sickle Cell (38)  ·  Heart Defects, Congenital (36)  ·  Stroke (36)  ·  Alzheimer Disease (34)  ·  Cardiovascular Diseases (34)  ·  HIV Infections (34)  ·  Inflammation (33)  ·  Obesity (32)

Interventions

Standard of Care (61)  ·  Magnetic Resonance Spectroscopy (36)  ·  Dexamethasone (23)  ·  Specimen Handling (22)  ·  Calcium Dobesilate (21)  ·  pembrolizumab (21)  ·  Cyclophosphamide (18)  ·  Insulin Glargine (18)  ·  Nivolumab (17)  ·  Cholecalciferol (15)  ·  Gemcitabine (15)  ·  Radiation (15)  ·  Radiotherapy (15)  ·  Bortezomib (14)  ·  Everolimus (13)

Countries

United States (1659)  ·  Canada (22)  ·  India (16)  ·  South Africa (14)  ·  Kenya (11)  ·  Germany (10)  ·  Italy (9)  ·  Australia (8)  ·  United Kingdom (8)  ·  Brazil (6)  ·  Mexico (6)  ·  Switzerland (6)  ·  Tanzania (6)  ·  China (5)  ·  Ethiopia (5)

Top investigators

Guillermo Umpierrez, MD (32)  ·  Nadine Rouphael, MD (18)  ·  Arshed Quyyumi, MD (11)  ·  Arshed A Quyyumi, MD (9)  ·  Lakshmanan Krishnamurti, MD (9)  ·  Colleen Kelley, MD, MPH (8)  ·  Guillermo E Umpierrez, MD (8)  ·  Kenneth Ogan, MD (7)  ·  Thomas R Ziegler, MD (7)  ·  Trisha Kesar, PT, PhD (7)  ·  Andrew H Miller, MD (6)  ·  Fayron Epps, PhD, RN (6)  ·  Jeanie Park, MD (6)  ·  Jennifer Mascaro, PhD (6)  ·  John Horan, MD (6)

Results publications

PMID 33884617, PMID 41701614, PMID 18477783, PMID 19127223, PMID 19366972, PMID 22805498, PMID 25184864, PMID 28369198, PMID 28465125, PMID 29253090, PMID 30524702, PMID 31303143, PMID 31401903, PMID 31504095, PMID 31799940, PMID 32384147, PMID 33752634, PMID 34174187, PMID 34298589, PMID 35224730, PMID 36240296, PMID 38743692, PMID 39513526, PMID 42549972, PMID 10350414, PMID 10568646, PMID 11556941, PMID 11587154, PMID 11587600, PMID 11710496, PMID 11981398, PMID 12490682, PMID 12748199, PMID 12791627, PMID 12925338, PMID 14556820, PMID 14667606, PMID 14717616, PMID 14724495, PMID 15087552, PMID 15312869, PMID 15349872, PMID 15354006, PMID 1550069, PMID 16126499, PMID 16730606, PMID 16760689, PMID 16787803, PMID 16894099, PMID 17030751

NIH funding

P30CA138292 (136), P30DK111024 (9), P30AG064200 (7), U19HD089881 (7), U19AI090023 (6), U54CK000601 (5), P01HL086773 (3), UL1TR002378 (3), 5UH3NS103550 (2), K01AT010488 (2), K12AR084234 (2), K24AT009893 (2), P01CA257906 (2), P50CA217691 (2), P50MH100029 (2)